These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21443283)

  • 1. Ganciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers).
    Croxtall JD
    Drugs; 2011 Mar; 71(5):603-10. PubMed ID: 21443283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
    Colin J; Hoh HB; Easty DL; Herbort CP; Resnikoff S; Rigal D; Romdane K
    Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis.
    Kaufman HE; Haw WH
    Curr Eye Res; 2012 Jul; 37(7):654-60. PubMed ID: 22607463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.
    Hoh HB; Hurley C; Claoue C; Viswalingham M; Easty DL; Goldschmidt P; Collum LM
    Br J Ophthalmol; 1996 Feb; 80(2):140-3. PubMed ID: 8814744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of herpes simplex virus epithelial keratitis.
    Wilhelmus KR
    Trans Am Ophthalmol Soc; 2000; 98():505-32. PubMed ID: 11190039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganciclovir ophthalmic gel in herpes simplex virus rabbit keratitis: intraocular penetration and efficacy.
    Castela N; Vermerie N; Chast F; Sauvageon-Martre H; Denis J; Godard V; Goldschmidt P; Pouliquen Y
    J Ocul Pharmacol; 1994; 10(2):439-51. PubMed ID: 8083563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG; Bartels SP; Gordon YJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications.
    Chou TY; Hong BY
    Ther Clin Risk Manag; 2014; 10():665-81. PubMed ID: 25187721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical ganciclovir in the treatment of acute herpetic keratitis.
    Tabbara KF; Al Balushi N
    Clin Ophthalmol; 2010 Aug; 4():905-12. PubMed ID: 20823931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pseudodendrites in herpes zoster ophthalmicus with topical ganciclovir 0.15% gel.
    Aggarwal S; Cavalcanti BM; Pavan-Langston D
    Cornea; 2014 Feb; 33(2):109-13. PubMed ID: 24322809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis - a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.
    Lin T; Gong L; Sun XH; Zhao NQ; Chen W; Yuan HP; Shao Y; Gao MH; Tang H
    Drug Des Devel Ther; 2013; 7():361-8. PubMed ID: 23761964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic interventions for herpes simplex virus epithelial keratitis.
    Wilhelmus KR
    Cochrane Database Syst Rev; 2008 Jan; (1):CD002898. PubMed ID: 18254009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
    Yao YF; Inoue Y; Kase T; Uchihori Y; Mori Y; Ohashi Y
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S126-32. PubMed ID: 8871163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model.
    Gordon YJ; Romanowski EG; Araullo-Cruz T
    Cornea; 1994 Nov; 13(6):516-20. PubMed ID: 7842711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oral valaciclovir on herpetic keratitis.
    Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
    Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic interventions for herpes simplex virus epithelial keratitis.
    Wilhelmus KR
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002898. PubMed ID: 17253484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Herpes Simplex Virus Infectious Epithelial Keratitis During Oral Acyclovir Therapy and Response to Topical Antivirals.
    Carter SB; Cohen EJ
    Cornea; 2016 May; 35(5):692-5. PubMed ID: 26989961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of acyclovir in the treatment of ulcerative herpetic keratitis.
    Shiota H
    Am J Med; 1982 Jul; 73(1A):307-10. PubMed ID: 7048917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel?
    Sahin A; Hamrah P
    Ophthalmol Eye Dis; 2012; 4():23-34. PubMed ID: 23650455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis to compare the efficacy of acyclovir 3% ophthalmic ointment to idoxuridine in curing herpetic keratitis by Day 7 of treatment.
    Balderson DE; Cai G; Fries MA; Kleinman DM; McLaughlin MM; Trivedi TM; Wurzelmann JI; Young SB
    BMC Ophthalmol; 2015 Apr; 15():42. PubMed ID: 25928630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.